Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 12

Personalized intervention to improve stress and sleep patterns for glycemic control and weight management in obese Emirati patients with type 2 diabetes: a randomized controlled clinical trial

Authors Mussa BM, Schauman M, Kumar V, Skaria S, Abusnana S

Received 10 January 2019

Accepted for publication 24 April 2019

Published 28 June 2019 Volume 2019:12 Pages 991—999

DOI https://doi.org/10.2147/DMSO.S201142

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 2

Editor who approved publication: Dr Konstantinos Tziomalos


Bashair M Mussa,1 Mia Schauman,2 Vijay Kumar,3 Sijomol Skaria,3 Salah Abusnana4,5

1Basic Medical Science Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 2Medical Research Department, Celolab, Dubai, United Arab Emirates; 3Rashid Centre for Diabetes and Research, Ajman, United Arab Emirates; 4Clinical Science Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 5Diabetes and Endocrinology Department, University Hospital Sharjah, Sharjah, United Arab Emirates

Background: There is growing evidence that stress and sleep deprivation are involved in development of type 2 diabetes (T2DM). The latter is one of the most challenging health problems in the UAE. Therefore, the present study aimed to investigate the effects of personalized intervention on glycemic and weight control in Emirati patients with T2DM. The intervention involved assessment and modification of stress levels and sleep patterns.
Methods: This was a randomized controlled study conducted on 51 Emirati patients with T2DM (age 18–60 years, body-mass index (BMI) ≥25 kg/m2): those in the intervention group who completed the trial numbered 18 and those in the control group who completed the trial numbered 17. Heart-rate variability was used for real-life and long-term assessments of stress, sleep, and recovery. Body weight, BMI, HbA1c and lipid profile were included in the investigation. The National Clinical Trial identifier number is NCT03644134.
Results: Percentage change in body weight was significantly greater (P<0.05) in the intervention group (–3.2±2.9) than the control group (–0.02). Percentage change in the BMI of the intervention group was –4.50±5.9, while the control group exhibited less change in BMI (–0.0003±3.3, P<0.05). In addition, a significant reduction in HbA1c was observed in the intervention group (–5.3±15.7) and an increase of 9.9±13.1 was observed in the control group (P<0.01).
Conclusion: The findings of the present study show that personalized approaches that reduce stress levels, increase recovery levels, and promote healthy sleep habits play an important role in weight management and glycemic control in T2DM.

Keywords: diabetes mellitus, obesity, stress, recovery levels, sleep pattern, heart rate variability


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]